ArticleTanaffos2025
Predicting COPD Severity by Red Cell Distribution Width as a Potential Marker.
Article in Tanaffos, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic obstructive pulmonary disease (COPD) is a condition of the lower airways and lungs with stable inflammation and alterations in the structure of small airways. There are some biomarkers linked to acute exacerbations of COPD (AECOPD). Red cell distribution width (RDW) is one of these biomarkers. To investigate the correlation between RDW and the severity of COPD, and to assess its relationship with the stage of airway obstruction in spirometry among COPD patients. Materials and Methods: In an 18-month retrospective study, a total of 255 participants were enrolled, including 170 patients with COPD (85 with stable COPD and 85 with acute exacerbations of COPD) and 85 age- and sex-matched healthy individuals. Demographic factors and blood laboratory tests were conducted for each group. The COPD groups had their COPD severity, spirometry parameters, and inflammation indices recorded and then compared. Results: RDW levels are increased in COPD patients (p<0.001). However, no statistically significant relationships between RDW values and CAT scores or mMRC grades were observed. Our analysis revealed that spirometry parameters and RDW levels are negatively correlated (p<0.05). Additionally, the RDW parameter has a positive and significant correlation with PCO Conclusion: Our findings indicate that RDW could serve as a potential predictor of COPD conditions, especially in spirometry parameters.
Indexed as
Identifiers
42890638PMC13672039What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.